智能自组合生物灵感水凝的最新进展:为新兴的医疗保健应用提供桥梁武器,从长椅到床边
Rishabh Ahuja1, Vaibhav Shivhare1, Anita Dutt Konar1,2,3
1Department of Applied Chemistry, Rajiv Gandhi Technological University, Bhopal, Madhya Pradesh, 462033, India.
Macromolecular rapid communications
|May 27, 2024
概括
基于的水凝为医疗用途提供更安全,对刺激有反应的生物材料. 了解的结构和自我组装是设计用于药物输送和伤口愈合应用的先进水凝支架的关键.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 化学工程是化学工程的重要组成部分.
背景情况:
- 响应刺激的水凝正在成为应对生物医学挑战的关键生物材料.
- 基于的自组装纳米材料为合成聚合物提供了可生物降解和更安全的替代品.
- 为了优化水凝功能,需要更深入地了解质结构与性质的关系.
研究的目的:
- 审查设计仿生策略和水凝过程的指导方针.
- 探索非共价相互作用在自组合中的作用.
- 总结了生物医学应用设计水凝的最新进展.
主要方法:
- 关于体自我组装和水凝的文献综述.
- 对驱动自我组装的非共价相互作用的分析.
- 最近在药物输送,抗菌,抗炎和伤口愈合方面的应用的汇编.
主要成果:
- 制定了适用于水凝的化物支架的定制指南.
- 突出了非共价相互作用在控制自我组装中的重要性.
- 展示了设计者化物水凝在医学中的各种应用.
结论:
- 设计者基凝代表了一个有前途的智能生物材料类别.
- 需要进一步的研究来将这些材料从实验室转化为临床实践.
- 跨学科的合作对于推进基凝技术至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...


